SMTL ID : 6b4w.1 (1 other biounit)

TTK in Complex with Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x CQ7: 4-{[4-(cyclopentyloxy)-5-(2-methyl-1,3-benzoxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxy-N-methylbenzamide(Non-covalent)

CQ7.1: 17 residues within 4Å: Chain A: K.35, I.37, V.45, Q.47, A.57, K.59, M.108, E.109, C.110, G.111, N.112, I.113, D.114, S.117, L.160, I.169, M.177 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.45, A:D.114, A:L.160, A:I.169, A:I.169, A:M.177 Hydrogen bonds: A:E.109, A:G.111, A:G.111, A:D.114, A:S.117

1 x CAC: CACODYLATE ION(Non-covalent)

CAC.2: 7 residues within 4Å: Chain A: H.145, P.219, K.220, V.223, S.287, I.288, P.289 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.288

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Riggs, J.R. et al., The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen. J. Med. Chem. (2017)

Release Date

2017-10-25

Peptides

Dual specificity protein kinase TTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase TTK

Related Entries With Identical Sequence